CSIMarket
 


Biotechnology & Pharmaceuticals Industry Profitability

Profitability Information & Trends 
  
Category:  



 

Biotechnology & Pharmaceuticals Industry Profitability Ratios 1 Q 2025 4 Q 2024 3 Q 2024 2 Q 2024 1 Q 2024
  Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Gross Margin 78.9 % 69.84 % 72.02 % 72.04 % 69.25 %
Gross Margin Annual (TTM) 77.71 % 70.74 % 70.62 % 69.35 % 69.67 %
Gross Margin Ranking # 8 # 26 # 23 # 22 # 21
EBITDA Margin 14.16 % 19.15 % 29.26 % 22.07 % -
EBITDA Margin Annual (TTM) 13.09 % 14.94 % 16.21 % 12.47 % 10.87 %
EBITDA Margin Ranking # 56 # 33 # 15 # 31 # 104
Operating Margin 6.95 % 12.39 % 8.7 % 11.44 % -
Operating Margin Annual (TTM) 4.16 % 2 % 1.02 % - -
Operating Margin Ranking # 71 # 57 # 70 # 56 # 104
Pre-Tax Margin 5.31 % 4.85 % 15.12 % 5.12 % -
Pre-Tax Margin Annual (TTM) 3.88 % - - - -
Pre-Tax Margin Ranking # 71 # 78 # 31 # 80 # 104
Net Margin 1.27 % 2.91 % 14.35 % 1.78 % -
Net Margin Annual (TTM) 1.33 % - - - -
Net Margin Ranking # 89 # 82 # 22 # 89 # 104


Comment on the 1 Q 2025 Gross Margin within the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry increased Gross Margin through reduction in Cost of Sales and despite contraction in Gross Profit by -4.62 % and Revenue -9.07 %. Gross Margin in 1 Q 2025 was 78.9 %, higher than Industry average.

On the trailing twelve months basis gross margin in 1 Q 2025 grew to 77.71 %.

Within Healthcare sector only one Industry has achieved higher gross margin. Gross margin total ranking has impoved so far to 8, from total ranking in previous quarter at 26.

Note, Numbers include only companies who have reported earnings results. Numbers change as more businesses report financial results. See the full List.

Gross Margin Statistics
High Average Low
102.36 % 76.69 % 61.7 %
4. quarter 2013   4. quarter 2021

Gross Margin Industry Ranking
Within: No.
Healthcare Sector # 2
Overall # 8


Other Gross Margins
Compare Industry's gross margin to Flyy's or S&P Gross profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Gross Margins Lowest Ranking Gross Margins
Profitability for Flyy's Suppliers Definiton of Gross Margin

Biotechnology & Pharmaceuticals Industry EBITDA Margin Statistics

 
EBITDA Margin Statistics
High Average Low
47.91 % 25.19 % -17.48 %
4. quarter 2019   1. quarter 2024

EBITDA Margin Industry Ranking
Within: No.
Healthcare Sector # 6
Overall # 56

EBITDA Margin Comment on the 1 Q 2025 within the Biotechnology & Pharmaceuticals Industry


Biotechnology & Pharmaceuticals Industry experienced contraction in Ebitda by -7.72 % and Revenue by -9.07 %, while Ebitda Margin fell to 14.16 % below Industry's average Ebitda Margin.

On the trailing twelve months basis Ebitda Margin in 1 Q 2025 fell to 13.09 %.

Within Healthcare sector 5 other industries have achieved higher ebitda margin. Ebitda margin total ranking has deteriorated compare to previous quarter from 33 to 56.

Other EBITDA Margins
Compare Industry's EBITDA margin to Flyy's or S&P Gross profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking EBITDA Margins Lowest Ranking EBITDA Margins
Profitability for Industry's Suppliers Industry Net Cash Flow Margin


Biotechnology & Pharmaceuticals Industry Operating Margin Statistics

 

Operating Margin Comment on the 1 Q 2025 within the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry's Revenue increased sequentially by -9.07 % faster than Operating Profit increase of 25.56 %, this led to contraction in Operating Margin to 6.95 %, below Industry average.

On the trailing twelve months basis operating margin in 1 Q 2025 grew to 4.16 %.

Within Healthcare sector 4 other industries have achieved higher operating margin. Operating margin total ranking has deteriorated compare to previous quarter from 57 to 71.



Operating Margin Statistics
High Average Low
41.3 % 19.56 % -31.63 %
4. quarter 2015   1. quarter 2024

Operating Margin Industry Ranking
Within: No.
Healthcare Sector # 5
Overall # 71

Biotechnology & Pharmaceuticals Industry Pre-Tax Margin Statistics

 


Pre-Tax Margin Statistics
High Average Low
38.85 % 15.93 % -36.73 %
4. quarter 2015   1. quarter 2024

Comment on the 1 Q 2025 Pre-Tax Margin in the Biotechnology & Pharmaceuticals Industry

Despite sequential Revenue deterioration in 1 Q 2025 of -9.07 % Biotechnology & Pharmaceuticals Industry managed to reduce total costs and increase Pre-Tax Income by 176.53 %. Pre-Tax Margin grew to 5.31 % below Industry average Pre-Tax Margin.

On the trailing twelve months basis Pre-Tax Margin in 1 Q 2025 grew to 3.88 %.

Within Healthcare sector 4 other industries have achieved higher Pre-Tax Margin. Pre-Tax Margin total ranking has impoved so far to 71, from total ranking in previous quarter at 78.
Pre-Tax Margin Industry Ranking
Within: No.
Healthcare Sector # 5
Overall # 71

Pre-Tax Margins
Compare Industry's pre-tax margin to Flyy's or S&P Net profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Flyy's Competitors Industry Tax Rate


Biotechnology & Pharmaceuticals Industry Net Margin Statistics

 





Net Margin Comment on the 1 Q 2025 in the Biotechnology & Pharmaceuticals Industry

Biotechnology & Pharmaceuticals Industry's Revenue increased sequentially by -9.07 % faster than Net Profit increase of -71.99 %, this led to contraction in Net Margin to 1.27 %, below Industry average.

On the trailing twelve months basis Net margin in 1 Q 2025 grew to 1.33 %.

Within Healthcare sector 6 other industries have achieved higher Net margin. Net margin total ranking has deteriorated compare to previous quarter from 82 to 89.

Net Margin Statistics
High Average Low
32.97 % 11.51 % -36.61 %
4. quarter 2015   1. quarter 2024
Net Margin Industry Ranking
Within: No.
Healthcare Sector # 7
Overall # 89

Other Net Margins
Compare Industry's net margin to Flyy's or S&P Net profits within Biotechnology & Pharmaceuticals Industry
Highest Ranking Net Margins Lowest Ranking Net Margins
Profitability for Flyy's Suppliers Definiton of Net Margin





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com